Evidence map›Paper›PMID 29599161›Full record

ArticleGenome announcements2018

Genome Sequence of the Amphotericin B-Resistant Candida duobushaemulonii Strain B09383.

Nancy A Chow, Lalitha Gade, Dhwani Batra, Lori A Rowe, Phalasy Juieng, Vladimir N Loparev, Anastasia P Litvintseva

Open access · diamondAbstract read
In one paragraph

Article in Genome announcements, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. First Genome Sequences of Two Multidrug-ResistantFrontiers in microbiology · 2020
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Nancy A ChowMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA yln3@cdc.gov.
Lalitha GadeMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Dhwani BatraBiotechnology Core Facility Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Lori A RoweBiotechnology Core Facility Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Phalasy JuiengBiotechnology Core Facility Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Vladimir N LoparevBiotechnology Core Facility Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Anastasia P LitvintsevaMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Centers for Disease Control and Prevention · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID29599161
PMCPMC5876483
OpenAlexW2794971827

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.